Researchers conducting vaccine clinical studies face unique challenges compared to those conducting trials in other disease states. These stem primarily from the significant time pressures that are created by varying seasonal heath concerns and the need to fast-track studies during outbreaks such as the coronavirus (COVID-19) (1).
Clinical trial sponsors need reliable methods to capture critical data directly from trial participants as they evaluate the safety and effectiveness of vaccines during development. Sponsors need to be able to implement these methods quickly to prevent trial delays.
Digital solutions are overcoming the data capture challenges that face vaccine developers and delivering the important data they need to bring new vaccines to market sooner.
|
